ロード中...
Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer
BACKGROUND: Progesterone receptor (PgR) negative breast cancer (BC) is an aggressive subtype with poor prognosis and reduced response to endocrine treatments. Several studies have suggested that androgen receptor (AR) expression is associated with a favorable tumor biology, longer recurrence free su...
保存先:
出版年: | Ther Adv Med Oncol |
---|---|
主要な著者: | , , , , , , , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
SAGE Publications
2020
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7502860/ https://ncbi.nlm.nih.gov/pubmed/32994808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920958355 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|